Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00164125 · ClinicalTrials.gov registry record · Phase 4

An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated Patients

A Phase 4 study of Constipation, sponsored by Braintree Laboratories.

Completed
Registry status
Phase 4
Development phase
300
Enrollment target
20
Study locations

NCT00164125 is a Phase 4 study of Constipation that has completed, run by Braintree Laboratories. The registered enrollment target is 300 participants, above the 200-participant average among 54 other Constipation trials with a reported enrollment target (50% higher). The trial reports 20 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00164125, a Phase 4 study of Constipation, has completed, sponsored by Braintree Laboratories.

COMPLETED
Registry status
Phase 4
Development phase
300 participants
Enrollment target
20
Study locations

Study Summary

To evaluate the safety of extended use of polyethyleneglycol3350 laxative in constipated patients.

Conditions Studied

Constipation

Interventions

  • DRUG polyethyleneglycol3350

Study Locations (20)

Florida

  • - Kissimmee
  • - Lake Worth
  • - Largo
  • - Ocoee
  • - St. Petersburg
  • - St. Petersburg
  • - West Palm Beach

Alabama

  • - Hoover
  • - Mobile
  • - Pell City
  • - Tallassee

Arizona

  • - Glendale
  • - Phoenix
  • - Scottsdale
  • - Tucson

California

  • - Anaheim
  • - Sacramento

Georgia

  • - Atlanta
  • - Marietta

District of Columbia

  • - Washington D.C.

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2003-07
Phase Phase 4

Sponsor

Braintree Laboratories

49 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00164125

The ClinicalTrials.gov registry entry for NCT00164125 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 200-participant average among 54 other Constipation trials with a reported enrollment target (50% higher). The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Constipation appearing as the primary indexed condition, and to 1 intervention - of which polyethyleneglycol3350 is the first listed.

NCT00164125 reports 20 study locations spanning 6 distinct geographic areas - top geographies include Florida, Alabama, Arizona.

Frequently Asked Questions

What is clinical trial NCT00164125 about?

NCT00164125 is a clinical study titled "An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated Patients". To evaluate the safety of extended use of polyethyleneglycol3350 laxative in constipated patients.

What is the current status of trial NCT00164125?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 2003-07.

What conditions does trial NCT00164125 study?

This clinical trial studies the following conditions: Constipation.

What interventions are being tested in trial NCT00164125?

The interventions under investigation include: polyethyleneglycol3350 (DRUG).

Who is sponsoring clinical trial NCT00164125?

This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00164125 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Constipation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Constipation

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.